Quality of life outcomes from a phase III trial exploring optimal sequencing of androgen deprivation therapy with external beam radiotherapy in localized prostate cancer

被引：0
|
作者：
Roy, Soumyajit
Grimes, Scott
Eapen, Libni
Malone, Choan E. Kyle
Craig, Julia
Morgan, Scott Carlyle
Malone, Shawn
机构：
[1] Ottawa Hosp, Canc Ctr, Ottawa, ON, Canada
[2] Ottawa Hosp, Ottawa, ON, Canada
[3] Ottawa Hosp, Res Inst, Ottawa, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
315
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Dose escalated external beam radiotherapy versus neoadjuvant androgen deprivation therapy and conventional dose external beam radiotherapy for clinically localized prostate cancer: Do we need both?
    Roach, Mack
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 (Suppl 2) : 26 - 28
  • [22] Quality of life in intermediate or high risk prostate cancer patients treated by external beam radiotherapy and brachytherapy with or without androgen deprivation
    Lacorte-Pi, T. M.
    Guix-Melcior, B.
    Guedea-Edo, F.
    PSYCHO-ONCOLOGY, 2006, 15 (02) : S296 - S297
  • [23] Dose Escalated External Beam Radiotherapy versus Neoadjuvant Androgen Deprivation Therapy and Conventional Dose External Beam Radiotherapy for Clinically Localized Prostate Cancer: Do we Need Both?
    Mack Roach
    Strahlentherapie und Onkologie, 2007, 183 : 26 - 28
  • [24] Combination of androgen deprivation therapy and radiotherapy for localized prostate cancer in the contemporary era
    D'Angelillo, Rolando M.
    Franco, Pierfrancesco
    De Bari, Berardino
    Fiorentino, Alba
    Arcangeli, Stefano
    Alongi, Filippo
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 93 (02) : 136 - 148
  • [25] Quality of life after external beam radiotherapy for localized prostate cancer: Comparison with other modalities
    Nakamura, Katsumasa
    Konishi, Kenta
    Komatsu, Tetsuya
    Ishiba, Ryo
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 (10) : 950 - 954
  • [26] Phase II study of neoadjuvant androgen deprivation followed by external-beam radiotherapy with 9 months of androgen deprivation for intermediate- to high-risk localized prostate cancer
    Heymann, Jonas J.
    Benson, Mitchell C.
    O'Toole, Kathleen M.
    Malyszko, Bozena
    Brody, Rachel
    Vecchio, Darleen
    Schiff, Peter B.
    Mansukhani, Mahesh M.
    Ennis, Ronald D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (01) : 77 - 84
  • [27] The utility of combined androgen deprivation therapy plus external beam radiotherapy in the intermediate-risk prostate cancer
    Sugimoto, M.
    Inokuchi, J.
    Shiota, M.
    Ohga, S.
    Eto, M.
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 : 100 - 100
  • [28] External beam radiotherapy with or without androgen deprivation therapy in elderly patients with high metastatic risk prostate cancer
    Dell'Oglio, Paolo
    Bandini, Marco
    Leyh-Bannurah, Sami-Ramzi
    Tian, Zhe
    Trudeau, Vincent
    Larcher, Alessandro
    Fossati, Nicola
    Moschini, Marco
    Gandaglia, Giorgio
    Capitanio, Umberto
    Briganti, Alberto
    Graefen, Markus
    Montorsi, Francesco
    Saad, Fred
    Karakiewicz, Pierre I.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (05) : 239.e9 - 239.e15
  • [29] IMPROVEMENT OF QUALITY OF LIFE IN FRAIL PATIENTS TREATED WITH ANDROGEN DEPRIVATION AND RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER: THE ADAPP PROTOCOL
    Voison, N.
    Gotteland, C.
    Joly, C.
    Peguret, N.
    Zilli, T.
    Miralbell, R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (08) : 527 - 527
  • [30] Quality-of-life outcomes after primary androgen deprivation therapy: Results from the prostate cancer outcomes study
    Potosky, AL
    Knopf, K
    Clegg, LX
    Albertsen, PC
    Stanford, JL
    Hamilton, AS
    Gilliland, FD
    Eley, JW
    Stephenson, RA
    Hoffman, RM
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (17) : 3750 - 3757
12345